Ganaxolone clinical trials

A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC OLE)

This study is looking at a new medicine called ganaxolone for people with epilepsy caused by Tuberous Sclerosis Complex (TSC). It aims to see how safe the medicine is and if it helps reduce seizures in adults.